Show simple item record

dc.contributor.authorSchifano, F.
dc.contributor.authorNapoletano, F.
dc.contributor.authorChiappini, S.
dc.contributor.authorGuirguis, A.
dc.contributor.authorCorkery, J. M.
dc.contributor.authorBonaccorso, S.
dc.contributor.authorRicciardi, A.
dc.contributor.authorScherbaum, N.
dc.contributor.authorVento, A.
dc.identifier.citationSchifano , F , Napoletano , F , Chiappini , S , Guirguis , A , Corkery , J M , Bonaccorso , S , Ricciardi , A , Scherbaum , N & Vento , A 2019 , ' New/emerging psychoactive substances and associated psychopathological consequences : Corrigendum ' , Psychological Medicine .
dc.identifier.otherPURE: 17435405
dc.identifier.otherPURE UUID: 695235d8-0bf2-43f2-9175-f22a80c2f01c
dc.identifier.otherScopus: 85072247707
dc.identifier.otherORCID: /0000-0001-8255-0660/work/63352150
dc.description© Cambridge University Press 2019. This article was submitted to Psychological Medicine with incorrect author affiliation. 'LVRKlinikum Essen, Klinik fur Psychiatrie und Psychotherapie, University of Duisburg-Essen, Duisburg, Germany' should read 'LVR-Klinikum Essen, Klinik fur Psychiatrie und Psychotherapie, University of Duisburg-Essen, Essen, Germany'. This has been updated per the above.
dc.description.abstractBackground. The present paper provides an updated review of both the large number of new/ novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences. Focus was here given on identification of those NPS being commented in specialised online sources and the related short-/long-term psychopathological and medical ill-health effects. Methods. NPS have been identified through an innovative crawling/navigating software, called the ‘NPS.Finder®’, created in order to facilitate the process of early recognition of NPS online. A range of information regarding NPS, including chemical and street names; chemical formula; three-dimensional image and anecdotally reported clinical/psychoactive effects, were here made available. Results. Using the ‘NPS.Finder®’ approach, a few thousand NPS were here preliminarily identified, a number which is about 4-fold higher than those figures suggested by European and international drug agencies. NPS most commonly associated with the onset of psychopathological consequences included here synthetic cannabinoids/cannabimimetics; new synthetic opioids; ketamine-like dissociatives; novel stimulants; novel psychedelics and several prescription and over-the-counter medicines. Conclusions. The ever-increasing changes in terms of recreational psychotropics’ availability represent a relatively new challenge for psychiatry, as the pharmacodynamics and pharmacokinetics of many NPS have not been thoroughly understood. Health/mental health professionals should be informed about the range of NPS; their intake modalities; their psychoactive sought-after effects; the idiosyncratic psychotropics’ combinations and finally, their medical and psychopathological risks.en
dc.relation.ispartofPsychological Medicine
dc.subjectApplied Psychology
dc.subjectPsychiatry and Mental health
dc.titleNew/emerging psychoactive substances and associated psychopathological consequences : Corrigendumen
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.description.statusPeer reviewed

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record